LifeClean, Here to Save Lives

7.1% of all patients contract a Healthcare-associated infection. Due to this 37 000 people die every year as a direct result of nosocomial infection. It generates approximately, according to the ECDC, 16 million extra days of hospital stay at a cost of €7000 000 000 every year – and that is only the cost of health care, not any indirect costs such as loss of income and emotional pain.

The most common infections are Clostridium difficile, Norovirus and the so called multidrug-resistant bacteria MRSA, VRE, ESBL, Pseudomonas aeruginosa and Acinetobacter.

LifeClean has, together with scientists from the “laboratoriemedicinska länskliniken” at the University Hospital in Orebro, Sweden, developed a product line that contains a patent pending solution for surface disinfection. It is a revolutionary, one of a kind, solution that can reduce nosocomial infections.

Shortcodes Ultimate

Follow us

Facebook
Twitter
LinkedIn

Newsletter

News

LifeClean International AB

1 week 2 days ago

LifeClean in South Korea. We attended the Food & Safety Conference in Seoul 2017, invited by Professor Ha to attend various seminars about ClO2, and Dr. Samira held a presentation about LifeClean.

LifeClean International AB

1 week 3 days ago

Here are some photos from our trip to USA earlier this month with Swecare. LifeClean’s CEO Mr. Thomas Lööw spent 7 intensive days with 37 meetings in Philadelphia, Maryland, New York and Washington DC, and also spent the day at the House of Sweden (the Swedish Embassy).

check_icon_44

A unique product for cleaning and surface disinfection for all types of microbes

check_icon_44

Eliminates Clostridium difficile in 60 seconds

check_icon_44

Ready to be used solution, right out of the bottle

The first solution in the world for an effective elimination of Clostridium difficile is finally here

Clostridium difficile is a spore forming bacteria that can survive during a long time in the surrounding area of infected patients, which makes it easier to spread to others – often in hospitals. The bacteria can produce toxins that can irritate the intestinal mucosa and cause severe diarrhea.

The consequences of Clostridium difficile is significant. 10 000 people are affected of it every year in Sweden and approximately 12% dies. The disease causes great social costs.

The repeated studies by scientists show that LifeClean is the first product on the market that eliminates Clostridium difficile in 2 or even 1 minute. It also eliminates multi-drug resistant bacteria such as MRSA, ESBL, VRE, Pseudomonas aeruginosa, Acinetobacter and Norovirus.

LifeClean is clinically proven

LifeClean is developed and tested in cooperation with the University Hospital of Orebro, Sweden. With the support from us, PhD Torbjörn Norén has conducted a scientific study that clearly shows that LifeClean is the first effective solution on the market for a complete elimination of Clostridium difficile, already at a short period of contact. The results of the study has been presented on Malta in March 2014, at the 14th congress for the International Federation of Infection Control.

Website Malware Scan